316 research outputs found

    The management of iron deficiency in inflammatory bowel disease

    Get PDF
    __Background__ Iron deficiency is a common and undertreated problem in inflammatory bowel disease (IBD). __Aim__ To develop an online tool to support treatment choice at the patient-specific level. __Methods__ Using the RAND/UCLA Appropriateness Method (RUAM), a European expert panel assessed the appropriateness of treatment regimens for a variety of clinical scenarios in patients with non-anaemic iron deficiency (NAID) and iron deficiency anaemia (IDA). Treatment options included adjustment of IBD medication only, oral iron supplementation, high-/low-dose intravenous (IV) regimens, IV iron plus erythropoietin-stimulating agent (ESA), and blood transfusion. The panel process consisted of two individual rating rounds and three plenary discussion meetings. __Results__ The panel reached agreement on 71% of treatment indications. 'No treatment' was never considered appropriate, and repeat treatment after previous failure was generally discouraged. For 98% of scenarios, at least one treatment was appropriate. Adjustment of IBD medication was deemed appropriate in all patients with active disease. Use of oral iron was mainly considered an option in NAID and mildly anaemic patients without disease activity. IV regimens were often judged appropriate, with high-dose IV iron being the preferred option in 77% of IDA scenarios. Blood transfusion and IV+ESA were indicated in exceptional cases only. __Conclusions__ The RUAM revealed high agreement amongst experts on the management of iron deficiency in patients with IBD. High-dose IV iron was more often considered appropriate than other options. To facilitate dissemination of the recommendations, panel outcomes were embedded in an online tool, accessible via http://ferroscope.com/

    Serological markers of extracellular matrix remodeling predict transplant‐free survival in primary sclerosing cholangitis

    Get PDF
    BACKGROUND: Primary sclerosing cholangitis is a progressive liver disease with a remarkably variable course. Biomarkers of disease activity or prognostic models predicting outcome at an individual level are currently not established. AIM: To evaluate the prognostic utility of four biomarkers of basement membrane and interstitial extracellular matrix remodeling in patients with primary sclerosing cholangitis. METHODS: Serum samples were available from 138 large‐duct primary sclerosing cholangitis patients (of which 102 [74%] with IBD) recruited 2008‐2012 and 52 ulcerative colitis patients (controls). The median follow‐up time was 2.2 (range 0‐4.3) years. Specific biomarkers of type III and V collagen formation (PRO‐C3 and PRO‐C5, respectively) and type III and IV collagen degradation (C3M and C4M, respectively) were assessed. The Enhanced Liver Fibrosis test, including procollagen type III N‐terminal peptide, tissue inhibitor of metalloproteinase‐1 and hyaluronic acid was assessed for comparison. RESULTS: All markers were elevated in primary sclerosing cholangitis compared to ulcerative colitis patients (P < 0.001). PRO‐C3 showed the largest difference between the two groups with a threefold increase in primary sclerosing cholangitis compared to ulcerative colitis patients. Patients with high baseline serum levels of all markers, except C3M, had shorter survival compared to patients with low baseline serum levels (P < 0.001). Combining PRO‐C3 and PRO‐C5 the odds ratio for predicting transplant‐free survival was 47 compared to the Enhanced Liver Fibrosis test's odds ratio of 11. CONCLUSIONS: Extracellular matrix remodeling is elevated in primary sclerosing cholangitis patients compared to ulcerative colitis patients. Furthermore, the interstitial matrix marker PRO‐C3 was identified as a potent prognostic marker and an independent predictor of transplant‐free survival in primary sclerosing cholangitis

    Air–Sea Interactions from Westerly Wind Bursts During the November 2011 MJO in the Indian Ocean

    Get PDF
    The life cycles of three Madden–Julian oscillation (MJO) events were observed over the Indian Ocean as part of the Dynamics of the MJO (DYNAMO) experiment. During November 2011 near 0°, 80°E, the site of the research vessel Roger Revelle, the authors observed intense multiscale interactions within an MJO convective envelope, including exchanges between synoptic, meso, convective, and turbulence scales in both atmosphere and ocean and complicated by a developing tropical cyclone. Embedded within the MJO event, two bursts of sustained westerly wind (>10 m s−1; 0–8-km height) and enhanced precipitation passed over the ship, each propagating eastward as convectively coupled Kelvin waves at an average speed of 8.6 m s−1. The ocean response was rapid, energetic, and complex. The Yoshida–Wyrtki jet at the equator accelerated from less than 0.5 m s−1 to more than 1.5 m s−1 in 2 days. This doubled the eastward transport along the ocean's equatorial waveguide. Oceanic (subsurface) turbulent heat fluxes were comparable to atmospheric surface fluxes, thus playing a comparable role in cooling the sea surface. The sustained eastward surface jet continued to energize shear-driven entrainment at its base (near 100-m depth) after the MJO wind bursts subsided, thereby further modifying sea surface temperature for a period of several weeks after the storms had passed
    corecore